D46 is a non-billable/non-specific diagnosis code from the 2025 ICD-10-CM used to classify the following condition: Myelodysplastic syndromes.
Use additional code
Code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Type 2 excludes
Drug-induced aplastic anemia (D61.1)
Codes
D46.0
Refractory anemia without ring sideroblasts, so stated
D46.1
Refractory anemia with ring sideroblasts
D46.2
Refractory anemia with excess of blasts [RAEB]
D46.A
Refractory cytopenia with multilineage dysplasia
D46.B
Refractory cytopenia with multilineage dysplasia and ring sideroblasts
D46.C
Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality
D46.4
Refractory anemia, unspecified
D46.Z
Other myelodysplastic syndromes
D46.9
Myelodysplastic syndrome, unspecified
Versions
2025
No changes
2024
No changes
2023
No changes
2022
No changes
2021
No changes
2020
No changes
2019
No changes
2018
No changes
2017
No changes
2016
New code